| Trial ID: | L0002 |
| Source ID: | NCT05714176
|
| Associated Drug: |
Ferric Pyrophosphate Liposomal
|
| Title: |
Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
CKD - Chronic Kidney Disease
|
| Interventions: |
DRUG: Ferric Pyrophosphate Liposomal|DRUG: Lactoferrin|DRUG: Iron Dextran Injection
|
| Outcome Measures: |
Primary: Hemoglobin measure, Measure oxygen in blood by measuring hemoglobin by coloremetric assay, 3 months | Secondary: Biomarkers measure, changes in serum levels of biological biomarkers( measure IL-6, hepcidin and GDF-15 by ELISA assay)., 3 months
|
| Sponsor/Collaborators: |
Sponsor: Menoufia University | Collaborators: Tanta University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-02-01
|
| Completion Date: |
2024-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2023-02-06
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT05714176
|
